RICHARD S. LINDAHL

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Richard S. Lindahl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RICHARD S. LINDAHL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. EVP, Chief Financial Officer Common Stock 239,700 $2,617,524 $10.92 06 Feb 2026 Direct
Emergent BioSolutions Inc. EVP, Chief Financial Officer Employee Stock Options (Right to Buy) 484,490 06 Mar 2025 Direct
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 90,000 02 Jan 2026 Direct

Insider Reports Filed by RICHARD S. LINDAHL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 06 Feb 2026 2 -$565,623 4 EVP, Chief Financial Officer 10 Feb 2026, 19:06
CMPX Compass Therapeutics, Inc. 02 Jan 2026 1 $0 4 Director 05 Jan 2026, 16:33
EBS Emergent BioSolutions Inc. 15 Oct 2025 1 -$47,952 4 EVP, Chief Financial Officer 17 Oct 2025, 16:02
EBS Emergent BioSolutions Inc. 08 Jun 2025 1 -$18,120 4 EVP, Chief Financial Officer 10 Jun 2025, 16:07
EBS Emergent BioSolutions Inc. 06 Mar 2025 2 $0 4 EVP, Chief Financial Officer 10 Mar 2025, 16:18
EBS Emergent BioSolutions Inc. 12 Feb 2025 3 -$13,135 4 EVP, Chief Financial Officer 04 Mar 2025, 16:05
CMPX Compass Therapeutics, Inc. 11 Feb 2025 1 $0 4 Director 13 Feb 2025, 17:11
EBS Emergent BioSolutions Inc. 15 Oct 2024 1 $0 4 EVP, Chief Financial Officer 17 Oct 2024, 17:04
EBS Emergent BioSolutions Inc. 08 Jun 2024 1 -$16,917 4 EVP, Chief Financial Officer 11 Jun 2024, 16:10
EBS Emergent BioSolutions Inc. 13 Mar 2024 1 $0 4 EVP, Chief Financial Officer 15 Mar 2024, 17:15
EBS Emergent BioSolutions Inc. 29 Feb 2024 2 -$31,508 4 EVP, Chief Financial Officer 04 Mar 2024, 18:42
EBS Emergent BioSolutions Inc. 21 Feb 2024 2 -$12,289 4 EVP, Chief Financial Officer 27 Feb 2024, 20:26
CMPX Compass Therapeutics, Inc. 09 Feb 2024 1 $0 4 Director 14 Feb 2024, 12:03
EBS Emergent BioSolutions Inc. 09 Jun 2023 3 $0 4 EVP, Chief Financial Officer 13 Jun 2023, 21:21
CMPX Compass Therapeutics, Inc. 21 Apr 2023 1 $0 4 Director 24 Apr 2023, 16:32
CMPX Compass Therapeutics, Inc. 21 Apr 2023 0 $0 3 Director 24 Apr 2023, 16:32
EBS Emergent BioSolutions Inc. 02 Mar 2023 3 $0 4 EVP, Chief Financial Officer 06 Mar 2023, 18:36
EBS Emergent BioSolutions Inc. 28 Feb 2023 1 -$13,296 4 EVP, Chief Financial Officer 02 Mar 2023, 13:42
EBS Emergent BioSolutions Inc. 23 Feb 2023 2 -$19,744 4 EVP, Chief Financial Officer 27 Feb 2023, 19:22
EBS Emergent BioSolutions Inc. 08 Feb 2023 2 -$31,747 4 EVP, Chief Financial Officer 10 Feb 2023, 19:35
EBS Emergent BioSolutions Inc. 28 Feb 2022 4 +$1,567,491 4 EVP, Chief Financial Officer 02 Mar 2022, 17:46
EBS Emergent BioSolutions Inc. 23 Feb 2022 2 -$63,539 4 EVP, Chief Financial Officer 25 Feb 2022, 16:18
EBS Emergent BioSolutions Inc. 22 Feb 2022 2 -$97,045 4 EVP, Chief Financial Officer 24 Feb 2022, 17:53
EBS Emergent BioSolutions Inc. 15 Nov 2021 1 +$112,380 4 EVP, Chief Financial Officer 15 Nov 2021, 16:53
EBS Emergent BioSolutions Inc. 08 May 2021 1 -$64,947 4 EVP, Chief Financial Officer 11 May 2021, 16:27